High-dose chemotherapy followed by autologous stem cell transplantation for metastatic rhabdomyosarcoma--a systematic review.
INTRODUCTION: Patients with metastatic rhabdomyosarcoma (RMS) have a poor prognosis. The aim of this systematic review is to investigate whether high-dose chemotherapy (HDCT) followed by autologous hematopoietic stem cell transplantation (HSCT) in patients with metastatic RMS has additional benefit...
Main Authors: | Frank Peinemann, Nicolaus Kröger, Carmen Bartel, Ulrich Grouven, Max Pittler, Rudolf Erttmann, Michael Kulig |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3044147?pdf=render |
Similar Items
-
First-line matched related donor hematopoietic stem cell transplantation compared to immunosuppressive therapy in acquired severe aplastic anemia.
by: Frank Peinemann, et al.
Published: (2011-01-01) -
Long-term survival after high-dose chemotherapy with autologous hematopoietic cell transplantation in metastatic breast cancer
by: Betty Ky Hamilton, et al.
Published: (2015-09-01) -
Successful Treatment with High-Dose Chemotherapy Followed by Autologous Stem-Cell Transplantation in a Patient with Metastatic Germ Cell Tumor
by: Jung Min Lee, et al.
Published: (2021-06-01) -
The effectiveness of high-dose chemotherapy with autologous hematopoietic stem cell transplantation in the treatment
by: T. V. Yukhta, et al.
Published: (2019-12-01) -
High dose chemotherapy with autologous stem cell transplantation in diffuse large B-cell lymphoma
by: Popp, Henning, et al.
Published: (2007-06-01)